Literature DB >> 11526548

Complementary and alternative medicine in chronic liver disease.

L B Seeff1, K L Lindsay, B R Bacon, T F Kresina, J H Hoofnagle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11526548     DOI： 10.1053/jhep.2001.27445

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  44 in total

1.  "Unintentional" acetaminophen overdose on the rise: who is responsible? Dr Robert J Fontana is interviewed by Paul C Adams.

Authors:  Robert J Fontana
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

2.  Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line.

Authors:  Pian Ye; Shuling Zhang; Lei Zhao; Jihua Dong; Shenghua Jie; Ran Pang; Shuli Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

3.  Reactivation of Pulmonary Tuberculosis in a Patient with Polygonum multiflorum Thunb-Induced Hepatitis.

Authors:  Hyun Chin Cho; Hyun Ju Min; Chang Yoon Ha; Hyun Jin Kim; Tae Hyo Kim; Woon-Tae Jung; Ok Jae Lee; In-Gyu Bae
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

Review 4.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

Review 5.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 6.  Herbal medicines for liver diseases.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

7.  Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.

Authors:  Ezra Gabbay; Ehud Zigmond; Orit Pappo; Nila Hemed; Mina Rowe; George Zabrecky; Robert Cohen; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

8.  Complementary and alternative medicine use in chronic liver disease patients.

Authors:  Leah M Ferrucci; Beth P Bell; Kathy B Dhotre; M Michele Manos; Norah A Terrault; Atif Zaman; Rosemary C Murphy; Grace R Vanness; Ann R Thomas; Stephanie R Bialek; Mayur M Desai; Andre N Sofair
Journal:  J Clin Gastroenterol       Date:  2010-02       Impact factor: 3.062

9.  Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

Authors:  Colin P White; Gerilynn Hirsch; Sunil Patel; Fatin Adams; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

Review 10.  Acupuncture in treating hepatic fibrosis: a review with recommendation for future studies.

Authors:  Jue Zhou; Yi Liang; Xian-Ming Lin; Rui-Jie Ma; Jian-Qiao Fang
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.